Dr Hyder A. Khoja,
PhD,P.Ag., Visiting Research Faculty-AKU, Chief Scientific Officer, NASH Pharmaceuticals, Inc.
Dr Khoja is an elocutionist philosopher, a visionary entrepreneur & a business savvy professional. He has had a distinguished professional career, within the high technology realms with strong adaptive ability in leading diverse regulatory programmes combined with functional expertise in science and policy domains. He has been extremely instrumental in advising to the board for several private and publicly traded start-up companies. Since then, he has been a liaison for many educational and industrial cooperative programmes.
At the end of the course, participants will be able to:
Who should attend?
- Aware or NASH and current anti-diabetic drugs in use for this treatment
- Aware of modern drug delivery system for faster and long-lasting action
- Able to develop research and licensing opportunities for formulating cannabinoids and Capsaicin plant derived compounds which has shown great potential in the treatment of NASH
Basic scientists, Medical students and other clinical & healthcare professionals
Department of Biological and Biomedical Sciences in collaboration with Department of Continuing Professional EducationThe Aga Khan University Department of Continuing Professional Education is accredited by the Pakistan Medical & Dental Council (PMDC) and the American Association of Continuing Medical Education (AACME) to provide continuing medical education.
The American Association of Continuing Medical Education (AACME) designates this live educational activity for a maximum of 01 AACME Category 1 Credit(s). Each participant should only claim those hours of credit that he/she actually spent in the educational activity.